(Q50586741)
Statements
Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group. (English)
1 reference
1 reference
S G Pauker
1 reference
J B Wong
1 reference
M H Ling
1 reference
J K Albrecht
1 reference
1 June 2000
1 reference
95
1 reference
6
1 reference
1524-1530
1 reference